ADVENZYMES SHARE PRICE PREDICTION
Recommendation → Expensive Star
- Week
- Month
- 3 Month
- Year
Open |
499.40
|
High |
504.75
|
Low |
496.90
|
52-Wk High |
571.00
|
52-Wk Low |
308.00
|
Interpretation of Candlestick Chart
In light of these factors, the current market condition for ADVENZYMES appears favorable for buyers, with the potential for further upside movement in the near term.
ADVENZYMES Share price Prediction:-
Period | Target 1 | Target 2 |
---|---|---|
2024 | 311.08 | 571.01 |
2025 | 376.08 | 636.01 |
2026 | 441.08 | 701.01 |
2027 | 506.08 | 766.01 |
2028 | 571.08 | 831.01 |
2029 | 636.08 | 896.01 |
2030 | 701.08 | 961.01 |
2031 | 766.08 | 1026.01 |
2032 | 831.08 | 1091.01 |
2033 | 896.08 | 1156.01 |
2034 | 961.08 | 1221.01 |
ADVENZYMES share price target 2024 to 2034 :-
ADVENZYMES’s share price target is the estimated value of the stock at a given point in time. It is based on our research, history, fundamentals, market trends and other factors.
2024
The minimum share price target for ADVENZYMES shares is Rs 311.08 and the maximum
target
price is Rs 571.01 by 2024
- Target1 : 311.08
- Target 2 : 571.01
2025
The minimum share price target for ADVENZYMES shares is Rs 376.08 and the
maximum target price is Rs 636.01 by
2025
- Target1 : 376.08
- Target 2 : 636.01
2026
The minimum share price target for ADVENZYMES shares is Rs 441.08 and the
maximum target price is Rs 701.01 by
2026
- Target1 : 441.08
- Target 2 : 701.01
2027
The minimum share price target for ADVENZYMES shares is Rs 506.08 and the
maximum target price is Rs 766.01 by
2027
- Target1 : 506.08
- Target 2 : 766.01
2028
The minimum share price target for ADVENZYMES shares is Rs 571.08 and the
maximum target price is Rs 831.01 by
2028
- Target1 : 571.08
- Target 2 : 831.01
2029
The minimum share price target for ADVENZYMES shares is Rs 636.08 and the
maximum target price is Rs 896.01 by
2029
- Target1 : 636.08
- Target 2 : 896.01
2030
The minimum share price target for ADVENZYMES shares is Rs 701.08 and the
maximum target price is Rs 961.01 by
2030
- Target1 : 701.08
- Target 2 : 961.01
2031
The minimum share price target for ADVENZYMES shares is Rs 766.08 and the
maximum target price is Rs 1026.01 by
2031
- Target1 : 766.08
- Target 2 : 1026.01
2032
The minimum share price target for ADVENZYMES shares is Rs 831.08 and the
maximum target price is Rs 1091.01 by
2032
- Target1 : 831.08
- Target 2 : 1091.01
2033
The minimum share price target for ADVENZYMES shares is Rs 896.08 and the
maximum target price is Rs 1156.01 by
2033
- Target1 : 896.08
- Target 2 : 1156.01
2034
The minimum share price target for ADVENZYMES shares is Rs 961.08 and the
maximum target price is Rs 1221.01 by
2034
- Target1 : 961.08
- Target 2 : 1221.01
**ADVENZYMES share price target prediction for 2024, 2025, and 2026 through 2034 is based on growth assumptions, future forecasts, and the existing state of the market. It is subject to change dependent on market sentiment.
ADVENZYMES Past Performance:-
1 Day →
1 Week →
1 Month →
3 Month →
1 Year →
Simple Moving Average (SMA) of ADVENZYMES :-
SMA 5 → 443.39
SMA 34 → 492.41
SMA 20 → 470.42
SMA 13 → 461.34
SMA 89 → 481.58
SMA 200 → 407.02
Exponential Moving Average (EMA) of ADVENZYMES :-
EMA 5 → 448.96
EMA 34 → 471.00
EMA 20 → 466.31
EMA 13 → 458.81
EMA 89 → 467.50
EMA 200 → 414.40
Bollinger Band ADVENZYMES :-
BBand Upper → 515.30
BBand Lower → 425.54
BBand Mid → 470.42
Moving Average Convergence ADVENZYMES :-
MACD →
MACD Signal →
MACD Hist →
Past Performance
ADVENZYMES Change in 1 day
-0.65%
Change in 1 day
ADVENZYMES Change in 1 Week
1.84%
Change in 1 Week
ADVENZYMES Change in 1 Month
-9.62%
Change in 1 Month
ADVENZYMES Change in 3 Month
8.12%
Change in 3 Month
ADVENZYMES Change in 1 Year
47.66%
Change in 1 Year
What is the current share price of ADVENZYMES ?
What is the target of ADVENZYMES tomorrow?
What is the full form of ADVENZYMES ?
Can I invest in ADVENZYMES share?
Is ADVENZYMES a buy hold or sell?
Durability : 0.99
Valuation : 0.18
Momentum : 71.54
Therefore, as per risk appetite of the investor whether to buy hold or sell the ADVENZYMES at current level.